What are the typical presentations and differential diagnoses of Granulomatosis with Polyangiitis (GPA), formerly known as Wegener granulomatosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Granulomatosis with Polyangiitis (Wegener Granulomatosis): Clinical Presentations and Differential Diagnoses

Typical Clinical Presentations

GPA characteristically presents with the "ELK triad" of ear-nose-throat (ENT), lung, and kidney involvement, with upper respiratory tract symptoms being the initial manifestation in 70-100% of cases. 1, 2

Upper Respiratory Tract Manifestations (Most Common Initial Presentation)

  • Nasal symptoms including crusting, stuffiness, and epistaxis are the most frequent presenting complaints 1
  • Chronic rhinosinusitis with possible nasal polyps occurs commonly 1
  • Nasal septal perforation develops in advanced cases 1
  • Otitis media and hearing loss may occur 1
  • Subglottic stenosis develops in 5-23% of treated patients, presenting insidiously with persistent cough, wheezing, and dyspnea that may initially be misdiagnosed as asthma 3

Lower Respiratory Tract Involvement (>90% of Patients)

  • Cough and hemoptysis occur in >95% of patients with lower respiratory tract disease 3
  • Pulmonary infiltrates and nodules are common radiographic findings 1
  • Diffuse alveolar hemorrhage can occur in severe cases, manifesting as diffuse alveolar infiltrates on chest imaging 3, 1
  • Tracheobronchial stenosis occurs in 15% of patients 3
  • Clinical presentation ranges from subacute nonspecific respiratory illness to rapidly progressive respiratory insufficiency 3

Renal Involvement (Hallmark Feature)

  • Glomerulonephritis is a defining feature of GPA, though not always present at initial presentation 1
  • Manifests as proteinuria, hematuria, and varying degrees of kidney failure 1
  • Kidney biopsy shows crescentic necrotizing glomerulonephritis, the pathologic hallmark 1
  • Elevated serum creatinine indicates pauci-immune necrotizing crescentic glomerulonephritis 4
  • Without treatment, renal involvement carries a 10-year survival rate of only 40% 2

Systemic and Other Manifestations

  • Peripheral neuropathy is a common systemic manifestation 1
  • Skin lesions including palpable purpura 1
  • Arthralgia and myalgia 1
  • Scleritis and other ocular manifestations 1
  • Non-specific systemic symptoms including fever, malaise, and weight loss 3

Diagnostic Evaluation

Laboratory Findings

  • PR3-ANCA (c-ANCA) is positive in 80-90% of GPA cases and is highly specific for this diagnosis 1, 4
  • Urinalysis shows hematuria and proteinuria in cases with renal involvement 1
  • Complete blood count with differential, inflammatory markers (ESR, CRP), and renal function tests (creatinine, BUN) are essential 1
  • Negative ANA helps exclude systemic lupus erythematosus 4

Histopathologic Confirmation

  • Biopsy of affected organs demonstrates necrotizing vasculitis of small arteries, granulomatous inflammation, and geographic necrosis 4, 5
  • Biopsy should be performed when feasible to confirm diagnosis 1

Differential Diagnoses

Primary Differential: Other ANCA-Associated Vasculitides

  • Microscopic polyangiitis (MPA) is the most important differential, sharing many features with GPA including ANCA positivity and renal involvement, but lacking granulomatous inflammation and upper respiratory tract involvement 1, 6
  • Eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome) should be considered, particularly when eosinophilia is present; overlap syndromes can occur with features of both GPA and EGPA 1, 7

Other Vasculitides and Systemic Conditions

  • Giant cell arteritis can present with chronic cough in patients >50 years old, but typically involves extracranial arteries of the head and neck with temporal artery abnormalities 3
  • Systemic lupus erythematosus (excluded by negative ANA) 4
  • Other small-vessel vasculitides 1

Organ-Specific Differential Diagnoses

For pulmonary manifestations:

  • Lung malignancy (when nodules or masses are present)
  • Tuberculosis or fungal infections (when cavitary lesions present)
  • Goodpasture syndrome (when alveolar hemorrhage is prominent)

For upper respiratory tract manifestations:

  • Chronic rhinosinusitis from other causes
  • Nasal malignancy
  • Cocaine-induced midline destructive lesions

For renal manifestations:

  • Other causes of rapidly progressive glomerulonephritis
  • Anti-GBM disease (Goodpasture syndrome)

Clinical Pitfalls and Caveats

  • Subglottic stenosis symptoms are insidious and may be misdiagnosed as asthma; abnormal inspiratory and expiratory flow-volume loops should prompt further investigation 3
  • ANCA can be negative in 10-20% of cases, so diagnosis should not be excluded based solely on negative serology 1, 4
  • Upper respiratory tract involvement may precede systemic manifestations by months to years 2
  • Staphylococcus aureus colonization occurs in 72% of GPA patients and is strongly implicated in disease relapses, warranting prophylactic trimethoprim/sulfamethoxazole 4
  • Relapse risk is up to 50% even with appropriate treatment 4

References

Guideline

Clinical Presentation and Management of Granulomatosis with Polyangiitis (GPA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinic manifestations in granulomatosis with polyangiitis.

International journal of immunopathology and pharmacology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Granulomatosis with Polyangiitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.

Seminars in respiratory and critical care medicine, 2018

Research

Update on the treatment of granulomatosis with polyangiitis (Wegener's).

Current treatment options in cardiovascular medicine, 2012

Research

An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2017

Related Questions

What is the treatment for Granulomatosis with Polyangiitis (GPA)?
Can Granulomatosis with Polyangiitis (GPA) increase the risk of E. coli infections in patients?
Can Granulomatosis with Polyangiitis (GPA) be confined to the bronchial airways without involving the lung parenchyma?
What is the diagnosis for a patient with a 6-month history of cough, sinusitis, and fever, found to have nasopharyngeal ulceration, nodular and cavity lesions on chest x-ray, positive PR3-ANCA (antineutrophil cytoplasmic antibodies against a cytosolic component), negative ANA (antinuclear antibodies), impaired renal function (elevated serum creatinine), and vasculitis with granulomatous inflammation on lung biopsy?
What is the treatment approach for a patient with chronic granulomatous polyangitis, particularly for those with impaired renal function and lung involvement?
What does it mean if a 7.5 week pregnant patient's ultrasound gestational age matches her expected gestational age based on her last menstrual period (LMP)?
What is the FLCCC (Front Line COVID-19 Critical Care) protocol for an adult patient with a presumed COVID-19 viral infection, including the use of ivermectin?
What is the recommended treatment for an outpatient with COVID-19, considering their vaccination status and risk for disease progression?
Is there a reason to repeat Lipoprotein(a) testing in a patient with a previously measured level of 23.4 mg/dL, which is considered low to normal?
What does it mean if the gestational age based on ultrasound and last menstrual period (LMP) match at 7.5 weeks of gestation, and how does this impact prenatal care for a patient with a confirmed pregnancy?
What is the recommended dosage of Paxlovid (nirmatrelvir and ritonavir) for the treatment of COVID-19 in adults with underlying medical conditions or impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.